[SLN] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Jun-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 0.00%
YoY- -14.29%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 8 385 385 0 0 0 0 -
PBT -3,328 -2,410 -2,410 -2,771 -2,771 -2,644 -2,644 16.56%
Tax 570 557 557 405 405 1,392 1,392 -44.82%
NP -2,758 -1,854 -1,854 -2,367 -2,367 -1,252 -1,252 69.21%
Tax Rate - - - - - - - -
Total Cost 2,766 2,239 2,239 2,367 2,367 1,252 1,252 69.54%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -34,475.00 -481.43 -481.43 0.00 0.00 0.00 0.00 -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.12 -0.08 -0.08 -0.10 -0.10 -0.05 -0.05 79.16%
EPS Diluted -0.12 -0.08 -0.08 -0.10 -0.10 -0.05 -0.05 79.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.